Jong‐Lyul Park

Ajou University — South Korea

Medicine · Health Sciences

28h-index2.7kcitations125works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(50), Lung Cancer Research Studies(49), Lung Cancer Diagnosis and Treatment(48), RNA modifications and cancer(19), Epigenetics and DNA Methylation(17)

Publications125 total

Genome-wide DNA methylome profiling to differentiate monozygotic twins
Forensic Science International Genetics·2025· 3 citedOpen Access
Abstract 3356: Construction of a 23-gene risk scoring system to predict disease recurrence and chemotherapy response in mucinous colorectal cancer
Cancer Research·2025
Abstract 2411: Identification of loss of heterozygosity-associated genes linked to loss of function in Korean population through in-silico analysis
Cancer Research·2025
The immune sensitivity caused by DUSP11, an RNA 5′-end maturation phosphatase, is adjusted by a human non-coding RNA, nc886
Cellular and Molecular Life Sciences·2025· 2 citedOpen Access
Highly accurate Korean draft genomes reveal structural variation highlighting human telomere evolution
Nucleic Acids Research·2025· 8 citedOpen Access
DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease
Clinical and Molecular Hepatology·2024· 9 citedOpen Access
Adenovirus expressing nc886, an anti-interferon and anti-apoptotic non-coding RNA, is an improved gene delivery vector
Molecular Therapy — Nucleic Acids·2024· 2 citedOpen Access
Whole-genome sequencing analysis of soybean diversity across different countries and selection signature of Korean soybean accession
G3 Genes Genomes Genetics·2024· 3 citedOpen Access
Table S2 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
Supplementary Figure 7 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
Table S3 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
Table S14 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
Supplementary Figure 5 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
Supplementary Figure 3 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
Table S8 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
Data from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
Table S11 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
Supplementary Figure 2 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
Table S3 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
Table S12 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without <i>EGFR</i> or <i>ALK</i> Alterations
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Seon‐Young Kim(39), Yong Sung Kim(14), Jeong‐Hwan Kim(12), Yong Sun Lee(9), Hyun‐Sung Lee(8), Ju‐Seog Lee(8), Mirang Kim(8), Seon‐Kyu Kim(8), Han‐Chul Lee(7), Kyu‐Sang Song(7), Kwang‐Man Woo(6), Yong‐Sung Kim(6), Seung‐Moo Noh(5), Hee-Jin Jang(4), In‐Sun Chu(4), Jong-Hwan Kim(4), Eun‐Hye Seo(4), Oh‐Hyung Kwon(4), Seung Hwan Lee(4), Byungho Lim(4)